Literature DB >> 6979164

Genetics of autoantibodies in relation to disease. An epidemiological study of two population series.

K Aho, P Sistonen, J Takala, K Sievers.   

Abstract

Familial occurrence of three types of autoantibodies, viz. rheumatoid factors, antinuclear antibodies and thyroid autoantibodies, was investigated in two population series: twins from the Finnish Twin Registry representing the adult twin population living in an urban area (76 monozygotic and 82 dizygotic same-sex twin pairs) and siblings from a middle-aged rural population subject to an ongoing epidemiological study (311 sibling groups comprising 801 subjects and 584 married couples). The observations were compatible with the concept of two components in the above autoantibody system. The major component is determined predominantly by environmental factors and is manifested with increasing age. The autoantibodies belonging to the minor, familial component occur in somewhat higher titers, exhibit certain specificity features of their own (RF reacting with rabbit gamma globulin), and are associated with "autoimmune" diseases.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6979164     DOI: 10.1111/j.0954-6820.1982.tb01929.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  3 in total

Review 1.  Antinuclear antibodies and juvenile chronic arthritis (JCA): search for a specific autoantibody associated with JCA.

Authors:  T R Southwood; P N Malleson
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

2.  Autoantibodies in patients with juvenile chronic arthritis and their immediate family relatives.

Authors:  T R Southwood; P J Roberts-Thomson; M J Ahern; K Shepherd; R McEvoy; J B Ziegler; J Edmonds
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

3.  Genetic structure of the population with rheumatoid arthritis in north east England: a genetic approach to define different subtypes.

Authors:  S S Papiha; J S Lanchbury; B Pal
Journal:  Ann Rheum Dis       Date:  1986-11       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.